Next Lesson - The Immunocompromised Host
Core
The Eukaryotic Targeting Problem
Fungi and parasites are eukaryotic pathogens. Like human cells, they package DNA in a nucleus, run translation on ribosomes, and organise metabolism through membrane-bound organelles. This shared cell structure is the main idea of the lesson. When a pathogen is a prokaryote, many essential structures differ sharply from the host, for example the peptidoglycan wall (the bacterial cell wall polymer) or the 70S ribosome (the bacterial ribosome, which is smaller than the human 80S ribosome). When the pathogen is a eukaryote, the number of truly unique essential targets shrinks, so selective toxicity (a drug harming the microbe but not the human host) becomes harder. This does not mean that treatment is impossible.
The practical consequence is not therapeutic nihilism (the belief that treatment is pointless). It is a demand for careful reasoning. Useful selectivity often sits in structures humans lack (a fungal wall) or in sterols (membrane fats such as cholesterol) and pathways that diverge enough to be exploitable. Residual shared machinery limits how clean that selectivity can be. Morphological form, lifecycle stage, anatomical site and immune status then predict both disease pattern and the diagnostic specimen that is worth taking. Immune failure as a broad clinical map belongs in The Immunocompromised Host. Here, host defence is used only to help predict the pattern of disease.
Fungal Cell, Morphology and Selective Targets
A fungal cell is a true eukaryote with a nucleus, organelles and a plasma membrane. Outside that membrane sits a multi-component cell wall that human cells do not possess. The wall is not a single polymer. A simplified but accurate map has three parts. Chitin is a tough structural polymer (a long chain of sugar units). Beta-glucans are sugar polymers that form much of the structural scaffold. The outer layer is rich in mannoprotein, which is protein carrying sugar chains. Exact layering and composition vary among fungi and with growth conditions. Because humans lack this wall, wall assembly is a relatively selective principle. Fungal membranes generally use ergosterol (the main fungal membrane sterol, a fat-like molecule) where human membranes use cholesterol. An exception is Pneumocystis, a fungus that causes pneumonia in people with weakened immunity and uses cholesterol rather than ergosterol as its main sterol. That sterol difference supports membrane- and ergosterol-pathway targeting as a second principle class. Selectivity is real but incomplete: fungi and humans still share eukaryotic protein synthesis, nucleic-acid handling and many metabolic routes, so wall and sterol differences narrow risk rather than erase it.
Morphology is a state, not a species name. Yeasts are unicellular fungi that typically reproduce by budding. Moulds grow as filamentous hyphae that branch into a mycelium. Classical thermal dimorphism (growing in two forms depending on temperature) describes pathogens that exist as mould in the environment and convert to a tissue form under host conditions. Two common mistakes are worth avoiding. First, tissue form is not always a yeast: Coccidioides (a fungus found in dry soil in parts of the Americas) characteristically forms spherules (large round structures filled with spores) in tissue. Second, Candida (a yeast that normally lives on the body) can switch among yeast, pseudohyphae (chains of elongated yeast cells that look like hyphae) and true hyphae. This switching between shapes is called polymorphism. It is different from the classical pattern of environmental mould and tissue form.
Both cells are eukaryotic; the fungal wall and ergosterol create selective contrast against a wall-free, cholesterol-using human cell.
SimpleMed original educational diagram
Yeast and mould are morphological states; classical dimorphism is condition-linked, with explicit spherule and Candida polymorphism nuances.
SimpleMed original educational diagram
Wall synthesis and ergosterol pathways are relatively selective zones; shared eukaryotic machinery means selectivity, not exclusivity.
SimpleMed original educational diagram
Fungal Disease Patterns
Three patterns organise common fungal disease better than a genus list. Dermatophytes occupy a superficial keratin niche: they exploit keratinised skin, hair and nails. Names such as tinea (ringworm, a fungal skin infection) describe the body site, so you do not need to memorise every species. The teaching point is ecological: organisms adapted to keratinised surfaces produce superficial disease when they establish there, rather than deep disease throughout the body by default.
Candida is typically a commensal on mucosal surfaces and skin. Colonisation is not infection. Disease emerges when the balance shifts: microbiome disruption (for example after broad antibacterial exposure), barrier breach (devices, surgery, maceration) or immune change can allow overgrowth and, in some settings, invasion. Mucosal overgrowth and invasive disease are related but not identical problems; the same organism can sit harmlessly until context changes. Severe immunodeficiency (a serious weakness of the immune system) is covered in The Immunocompromised Host and, where relevant, in Human Immunodeficiency Virus.
Aspergillus illustrates an inhalation pattern. Conidia (airborne fungal spores) are inhaled routinely from the environment. Healthy airway defences usually clear them: mucus moved along by cilia (tiny hair-like projections) removes some, and alveolar macrophages (scavenger cells in the air sacs of the lung) engulf and destroy many of the rest. Macrophages also recruit neutrophils, which help to clear the fungus. Invasive hyphal growth is therefore shaped strongly by failure of host defence rather than by mere exposure. Whether inhaled spores stay harmless or cause deep infection depends on fungal form (conidium versus invasive hypha) and on how well the host's defences work.
Protozoa versus Helminths
Parasitic eukaryotes split usefully into two structural classes. Protozoa are unicellular. Many can multiply within a single host, so a small inoculum (the starting number of organisms) may expand into a large population through repeated binary fission (one cell splitting into two) or other asexual cycles, depending on the organism. Life stages often include an active trophozoite (the feeding, multiplying form) and a more durable cyst, but the core preclinical contrast is unicellularity plus the ability to multiply inside the host.
Helminths are multicellular worms with egg, larval and adult stages. Many adult helminths do not amplify as adults inside the definitive human host, so worm burden often reflects cumulative exposure intensity rather than exponential replication after one contact. That statement is not absolute: some helminths support autoinfection (re-infecting the same person), in which larval stages re-establish infection without a new external exposure, so burden can rise even though no new worms are acquired. Eosinophilia (a raised eosinophil count in the blood) is discussed with tissue migration below. It is not a feature of every parasitic infection, so it does not separate protozoa from helminths.
Protozoa: unicellular, often multiplying in-host. Helminths: multicellular staged worms; burden often tracks exposure, with autoinfection exceptions.
SimpleMed original educational diagram
Lifecycle Grammar
Host terms describe reproductive roles, not clinical severity. The definitive host is the host in which sexual reproduction occurs, or in which the adult reproductive stage of a helminth resides. The intermediate host supports larval development or asexual amplification. A patient can be severely ill in an intermediate-host role; "definitive" never means "the sickest host".
A biological vector (an animal, such as a mosquito, that carries the parasite between hosts) transmits the parasite and may itself be a host in the lifecycle sense. In malaria, the mosquito both transmits and houses the sexual cycle, so it is vector and definitive host at once. Keeping these definitions strict prevents the common reversal of mosquito and human roles and prepares the malaria and Schistosoma maps that follow. Travel context and prevention belong in Travel-related Infections; this lesson keeps geography subordinate to lifecycle grammar.
Malaria as a Lifecycle Map
Malaria is the clearest two-host map for pre-clinical students. Learn the sequence of stages, not the individual species.
- A female Anopheles mosquito injects sporozoites (the infective stage) in its saliva when it takes a blood meal.
- Sporozoites reach the liver and undergo asexual development, releasing merozoites (the stage that invades red cells). In Plasmodium vivax and Plasmodium ovale, some parasites stay dormant in the liver (as hypnozoites) and can cause relapse months or years after the first infection.
- Merozoites invade red cells; repeated blood-stage asexual cycles generate the forms that drive clinical symptoms and that blood films can detect.
- Some parasites differentiate into gametocytes (sexual forms that can infect a mosquito), which do not themselves complete the sexual cycle in the human.
- A mosquito ingesting gametocytes allows fertilisation and further development, including the oocyst stage (a cyst on the mosquito gut wall in which sporozoites develop), producing new sporozoites that migrate to salivary glands and restart the cycle.
Because sexual reproduction occurs in the mosquito, the mosquito is the definitive host and the human is the intermediate host. Blood stages matter twice: they explain fever and systemic illness, and they are the stages seen under the microscope. This map deliberately omits prophylaxis, drug regimens, geography lists and species morphology atlases; those belong elsewhere. The diagnostic implication (thick versus thin films) returns in the final section.
Mosquito definitive (sexual); human intermediate (liver then blood asexual stages); blood forms drive symptoms and film diagnosis.
SimpleMed original educational diagram
Tissue Migration, Eosinophilia and Schistosoma
Eosinophilia can be a useful clue when helminths migrate through tissues and contact the immune system. It is not a universal marker of "any parasite", and a normal eosinophil count does not reliably exclude parasitic infection. Adult worms living in the gut cavity without entering tissue (intraluminal) or cysts that are still intact may provoke little blood eosinophilia even when infection is present. Treat a raised count as a clue that depends on the stage of infection, not as a test that confirms or excludes it.
Schistosoma is the single helminth worked example. Humans are the definitive hosts: adult worms live in venous plexuses and reproduce sexually. Freshwater snails are intermediate hosts that release cercariae (free-swimming larvae). Cercariae penetrate intact skin, become schistosomula (young worms), and migrate before adults establish in veins. Eggs must leave the host to continue the cycle, but many lodge in tissues. Much of the pathology is driven by granulomatous responses (the immune system walling off the eggs in clumps of immune cells called granulomas) rather than by the adult worms alone. Intensity of infection often tracks exposure because adult worms (flukes) do not multiply in humans. The key points are skin entry, the two hosts, and tissue damage caused by the immune response to the eggs. Innate and adaptive injury mechanisms sit in Innate Immunity and Adaptive Immunity.
Diagnosis Follows Form, Site and Stage
Choose tests by asking what form the organism takes, where it lives anatomically, and which stage is present now. Fungal microscopy and histopathology (examining tissue samples under a microscope) can show morphology and tissue invasion, linking structure to disease rather than mere presence. Culture can recover viable fungi and identify the species, but growth may be slow, and culture of a colonising or contaminating organism needs clinical context. Beta-D-glucan is a component of the wall of many fungi, so a positive result does not point to one organism. Some fungi make little of it, and false positives occur. Galactomannan (a sugar released from the Aspergillus wall) supports Aspergillus infection only when it is read alongside the patient's risk factors and the type of specimen tested. Nucleic acid amplification tests (NAATs) can detect very small amounts of fungal DNA, but they cannot show that the fungus is alive and invading tissue. Serology (testing blood for antibodies) may reflect prior exposure rather than current active disease.
For malaria, thick blood films concentrate parasites, so they are better at detecting low numbers; thin films preserve red-cell morphology for species features and parasitaemia estimates (the proportion of red cells that are infected). A single negative film does not exclude malaria: if the first films are negative, they are repeated 12 to 24 hours later and again after a further 24 hours. Rapid antigen tests, which detect parasite proteins in blood, can also be used, but they are less reliable for species other than Plasmodium falciparum. For intestinal helminths, egg shedding can be intermittent, so one negative stool sample does not rule out infection: the sample may need to be repeated. There is no single universal "parasite blood test" that replaces this form-site-stage logic.
The main points of the lesson are these. Shared eukaryotic biology narrows the number of unique drug targets. Fungal wall and ergosterol differences create incomplete selectivity. Morphological form and host niche shape fungal disease. Protozoa and helminths differ in structure and in how they multiply. Definitive and intermediate host roles organise parasite lifecycles. Malaria and Schistosoma make those roles concrete. Diagnosis succeeds when the method matches the form, site and stage of the organism.
Reviewed by: Dr. Marcus Judge
- 148
